RA CAPITAL MANAGEMENT, L.P. - 23 Mar 2023 Form 4 Insider Report for DICE Therapeutics, Inc.

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
N/A
Transactions as of
23 Mar 2023
Net transactions value
+$13,457,372
Form type
4
Filing time
27 Mar 2023, 17:01:02 UTC
Previous filing
27 Feb 2023
Next filing
30 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DICE Common Stock Purchase $4,136,224 +155,089 +2.6% $26.67 6,217,593 23 Mar 2023 See Footnotes F1, F2, F8
transaction DICE Common Stock Purchase $5,168,041 +192,335 +3.1% $26.87 6,409,928 24 Mar 2023 See Footnotes F3, F4, F8
transaction DICE Common Stock Purchase $4,153,107 +151,132 +2.4% $27.48 6,561,060 27 Mar 2023 See Footnotes F5, F6, F8
holding DICE Common Stock 786,407 23 Mar 2023 See Footnotes F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $26.29 to $27.20; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
F2 Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund").
F3 This transaction was executed in multiple trades at prices ranging from $26.46 to $27.20; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
F4 Held directly by the Fund.
F5 This transaction was executed in multiple trades at prices ranging from $26.93 to $27.76; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
F6 Held directly by the Fund.
F7 Held directly by the RA Capital Nexus Fund II, L.P. (the "Nexus Fund").
F8 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.